{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:50:25Z","timestamp":1783615825728,"version":"3.55.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate whether a high-dose oxytocin regimen reduces the risk for primary cesarean birth and other obstetric morbidities when compared with standard dosing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>In a double-blind randomized clinical trial of nulliparous women at or beyond 36 weeks of gestation who were undergoing augmentation of labor, participants were assigned to high-dose (initial and incremental rates of 6 milliunits\/min) or standard-dose (initial and incremental rates of 2 milliunits\/min) oxytocin regimens. The primary outcome was cesarean birth. Prespecified secondary outcomes included labor duration, clinical chorioamnionitis, endometritis, postpartum hemorrhage, Apgar score 3 or less at 5 minutes, umbilical artery acidemia, neonatal intensive care unit admission, perinatal death, and a severe perinatal morbidity composite. A sample size of 501 per group (n=1,002) was planned to detect a 6.6% absolute reduction in rate of the primary outcome, from 20% in the standard-dose group to 13.4% in the high-dose group with 80% power.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>From September 2015 to September 2020, 1,003 participants were randomized\u2014502 assigned to high-dose and 501 assigned to standard dosing. The majority of participants were of White race, were married or living as married, and had commercial insurance. Baseline characteristics between groups were similar. The primary outcome occurred in 14.5% of those receiving high-dose compared with 14.4% of those receiving standard-dose oxytocin (relative risk, 1.01; 95% CI 0.75\u20131.37). The high-dose group had a significantly shorter mean labor duration (9.1 vs 10.5 hours; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001), and a significantly lower chorioamnionitis incidence (10.4% vs 15.6%; relative risk, 0.67; 95% CI 0.48\u20130.92) compared with standard dosing. Umbilical artery acidemia was significantly less frequent in the high-dose group in complete case analysis, but this finding did not persist after multiple imputation (relative risk, 0.55; 95% CI 0.29\u20131.04). There were no significant differences in other secondary outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Among nulliparous participants who were undergoing augmentation of labor, a high-dose oxytocin regimen, compared with standard dosing, did not affect the cesarean birth risk but significantly reduced labor duration and clinical chorioamnionitis frequency without adverse effects on perinatal outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n            <jats:p>\n                                 ClinicalTrials.gov, NCT02487797.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000004399","type":"journal-article","created":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T19:37:00Z","timestamp":1620589020000},"page":"991-998","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":28,"title":["High-Dose Compared With Standard-Dose Oxytocin Regimens to Augment Labor in Nulliparous Women"],"prefix":"10.1097","volume":"137","author":[{"given":"Moeun","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany T.","family":"Stetson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Tunney","family":"Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Clare","family":"Vanecko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Grobman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan M.","family":"Peaceman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"R1-20250423","first-page":"1","article-title":"Births: final data for 2017","volume":"67","author":"Martin","year":"2018","journal-title":"Natl Vital Stat Rep"},{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1503\/cmaj.060870","article-title":"Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term","volume":"176","author":"Liu","year":"2007","journal-title":"CMAJ"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"36.e1","DOI":"10.1016\/j.ajog.2008.03.007","article-title":"Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery","volume":"199","author":"Clark","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20250423","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3109\/14767058.2011.553695","article-title":"The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality","volume":"24","author":"Solheim","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/01.AOG.0000219750.79480.84","article-title":"Maternal morbidity associated with multiple repeat cesarean deliveries","volume":"107","author":"Silver","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(03)14896-9","article-title":"Caesarean section and risk of unexplained stillbirth in subsequent pregnancy","volume":"362","author":"Smith","year":"2003","journal-title":"Lancet"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.AOG.0000444441.04111.1d","article-title":"Safe prevention of the primary cesarean delivery. Obstetric Care Consensus No. 1. American College of Obstetricians and Gynecologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0b013e31821e5f65","article-title":"Indications contributing to the increasing cesarean delivery rate","volume":"118","author":"Barber","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"147.e1","DOI":"10.1016\/j.ajog.2014.03.017","article-title":"Can differences in obstetric outcomes be explained by differences in the care provided? The MFMU Network APEX study","volume":"211","author":"Grobman","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"622.e1","DOI":"10.1016\/j.ajog.2008.01.039","article-title":"Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin","volume":"198","author":"Hayes","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"35.e1","DOI":"10.1016\/j.ajog.2008.06.010","article-title":"Oxytocin: new perspectives on an old drug","volume":"200","author":"Clark","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/0002-9378(95)90444-1","article-title":"Low-dose versus high-dose oxytocin augmentation of labor\u2014a randomized trial","volume":"173","author":"Xenakis","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1471-0528.1987.tb03142.x","article-title":"A randomized control study of oxytocin augmentation of labour. 1. Obstetric outcome","volume":"94","author":"Bidgood","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12874-017-0414-5","article-title":"Multiple imputation for handling missing outcome data when estimating the relative risk","volume":"17","author":"Sullivan","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/aje\/kwp425","article-title":"Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation","volume":"171","author":"Lee","year":"2010","journal-title":"Am J Epidemiol"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.wombi.2018.09.002","article-title":"High-dose versus low-dose of oxytocin for labour augmentation: a randomised controlled trial","volume":"32","author":"Selin","year":"2019","journal-title":"Women Birth"},{"key":"R19-20250423","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2288-7-30","article-title":"The Hawthorne Effect: a randomised, controlled trial","volume":"7","author":"McCarney","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/AOG.0000000000001533","article-title":"Simulation training for forceps-assisted vaginal delivery and rates of maternal perineal trauma","volume":"128","author":"Gossett","year":"2016","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T19:06:23Z","timestamp":1745435183000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004399"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004399","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"2021-01-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}